Navigation Links
New pacemaker reduces risk of heart failure

New study says heart failure victims who get a new kind of pacemaker have only half the usual risk of being hospitalized with worsening heart trouble.// The device, Medtronic's InSync pacemaker, has been implanted in more than 3,000 people in the US since its approval by the FDA.

It is intended for people with a particular form of heart failure, a debilitating illness in which people suffer shortness of breath because their hearts do not beat strongly enough. Overall, an estimated 5 million Americans have heart failure, and it is considered to be the only major form of heart trouble that is growing in prevalence.

The new pacemakers deliver an electrical impulse that synchronizes the ventricles so their walls pump in unison. Installing the pacemaker, which requires attaching three wires, can be tricky. On their first attempt, doctors often take 2 to 4 hours to cope up with them. But after they get more skilled, this falls to about an hour and a half. The procedure is successful in about 97 % of cases.
'"/>




Page: 1

Related medicine news :

1. Stress reduces your immunity- startling but true!!!!!
2. Thirty minutes of work up per day reduces the risk of Diabetes
3. Aspirin reduces deaths
4. Tomato Sauce reduces Cancer Risk- Study
5. Calcium reduces colon cancer risk
6. Vitamin D reduces heart risk
7. Back exercises reduces Osteoporosis
8. Caffeine reduces infant blood flow
9. Radiation reduces cancer recurrence
10. Tamoxifen reduces breast cancer risk
11. Tamoxifen reduces breast cancer risk
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New pacemaker reduces risk heart failure

(Date:7/7/2015)... ... 07, 2015 , ... CSG Government Solutions, a ... the Department of Vermont Health Access to provide Quality Assurance (QA) and Independent ... Integrated Contact Center System project. , Vermont is implementing a strategic approach to ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... Respected southern ... awards in 2015, marking him as an attorney who has sharp legal skills ... both a Client Distinction Award for 2015 from Martindale-Hubbell and a Top 10 Award ...
(Date:7/6/2015)... Angeles, CA (PRWEB) , ... July 06, 2015 , ... On June 22, 2015, Fox News in a report titled ... by the time they turn age 35 a quarter of all women in the U.S. will ... hair loss is stigmatized and rarely discussed. One woman, a former beauty queen, who ...
(Date:7/6/2015)... ... ... The Asian-Pacific market for rheumatoid arthritis therapeutics reached a value of more than ... over 3.2 percent in the years to come to hit the USD 6.9 billion ... anticipated launch of a number of promising pipeline candidates and an increase in the ...
(Date:7/6/2015)... Chester, NJ (PRWEB) , ... July 06, 2015 ... ... CancerHopeNetwork.org. The redesigned site allows newly-diagnosed cancer patients, caregivers and medical professionals to ... who has survived the same cancer. , “Receiving a cancer diagnosis is often ...
Breaking Medicine News(10 mins):Health News:CSG Government Solutions Selected by the Department of Vermont Health Access to Provide Quality Assurance and Independent Verification and Validation Services 2Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 2Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 3Health News:The Stigma of Female Hair Loss and Hair Restoration Solutions 2Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2
... UC Davis professor Adela de la Torre, a national ... five-year, $4.8 million,federal grant to discover the best ways ... The study, called "Ninos Sanos, Familia Sana" (Healthy Children,Healthy ... of,Firebaugh and San Joaquin. "More than four in ...
... The experimental agent selumetinib has shown promising results ... multi-institutional clinical trial led by cancer researchers at The ... (ARRY-142886), blocks a protein called MEK, which cancer cells ... malignancy of cells lining the bile ducts and gall ...
... HealthDay Reporter , MONDAY, April 25 (HealthDay News) -- ... along with the bullies themselves -- made more frequent visits ... and injuries than their other classmates, according to new research ... be getting frequent stomachaches from being picked on," said Eric ...
... Reporter , MONDAY, April 25 (HealthDay News) -- A new study ... -- in areas such as job success, education and any brushes ... motivated you are when you take the test. In other ... life, "but it might not predict it for the reason you ...
... G. James Cancer Hospital and Richard J. Solove Research ... convening a high-level group of stakeholders to discuss ... drugs for the treatment of cancer. ... (FDA) released a Guidance Document addressing the protocol researchers ...
... MONDAY, April 25 (HealthDay News) -- New research suggests that ... regulating a brain wave known as the alpha rhythm, which ... small study, researchers found that those participants using meditation were ... told where to direct their attention -- after they finished ...
Cached Medicine News:Health News:$4.8 million study will fight child obesity in California 2Health News:$4.8 million study will fight child obesity in California 3Health News:$4.8 million study will fight child obesity in California 4Health News:Targeted agent selumetinib shows promise in biliary cancer 2Health News:Bullied Kids Showing Up in School Nurses' Offices 2Health News:Bullied Kids Showing Up in School Nurses' Offices 3Health News:Do IQ Tests Measure More Than Intelligence? 2Health News:Public session of the Cancer Drug Development Roundtable at Ohio State 2Health News:Meditation May Help Brain Block Out Distractions 2
(Date:7/6/2015)... July 6, 2015 E-QURE Corp (OTCQB: EQUR), ... live at VirtualInvestorConferences.com on July 9, 2015. ... http://tinyurl.com/e-qure-presentation This will be a ... ask the company questions in real-time - both in ... trade booth." If attendees are not able to join ...
(Date:7/6/2015)... -- Celtaxsys, Inc., a clinical stage pharmaceutical development company ... orphan inflammatory disease indications, announced today that it has ... (FDA) to begin a Phase 2 clinical trial of ... patients in the US. The regulatory submissions to the ... be filed soon after. This groundbreaking clinical study, testing ...
(Date:7/6/2015)... , July 6, 2015  OncoSec Medical Inc. ... intratumoral cancer immunotherapies, today announced the appointment of ... of Vice President of Market Development, effective July 6, ... for evaluating, designing, and executing on the company,s market ... "I,m very excited to welcome Joann to the ...
Breaking Medicine Technology:E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development 2OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development 3
... Portable Slit-Lamp. Rechargeable, cordless ... for any purpose , Easy selection ... blue filter , Extra-bright halogen lamp ... main and extra ,power pack , ...
The PillCam™ ESO video capsule is specifically designed to view the inner lining of the Esophagus. The capsule is equipped with miniature cameras on both ends and is about the size of a multi-v...
World's first commercially available vacuum assisted biopsy device for MRI....
... Now you can perform stereotactic, ultrasound ... the convenience of your office. Use the ... safer, easier and more clinically advanced method ... its best for the women who trust ...
Medicine Products: